By Dailymail. A California woman who became one of the world's most successful porn stars has warned other females against going down the same career path after she moved on to become a preacher. Changes: Former porn star Brittni De La Mora, 31, has warned women against following down her same career path because of how it lives forever on the internet. Career: Performing under the stage name Jenna Presley, Brittni pictured in at an adult entertainment convention , now 31, appeared in about adult videos. In an interview with Fox News , Brittni revealed why she would advise against other women joining the porn industry.
Narrow-gauge railways in Asia
Amber Ruffin And Sister Recall 'Hilarious' Encounter With Racism On 'Late Night' | HuffPost
Get free ground shipping with Ship Saver. Learn more. I love our 81 year old heritage and we are working hard to serve customers everyday. We are proud to be a fiercely independent family owned company competing with large big box and large conglomerates. We embrace the challenge and take our responsibility with every customer seriously. We would love your feedback.
Amber Ruffin And Sister Recall 'Hilarious' Encounter With Racism On 'Late Night'
Fox Jenna Jameson and Traci Lords are but a few previously X-rated performers who have managed to parlay their controversial careers into the mainstream. Many times porn stars are considered social outcasts once they leave the adult entertainment industry, but there are a few previously X-rated performers who have managed to parlay their controversial careers into the mainstream. Jenna Jameson Once dubbed the queen of the adult entertainment genre, she used her fan base to gain the attention of Hollywood. Sunny Leone She was born Karenjit Kaur Vohra and later adapted her stage persona and went on to star in dozens of adult films.
Equities mostly rose in Asia on Tuesday, with support coming from a Wall Street rally fuelled by merger activity and hopes for a coronavirus vaccine. After their first two successive weekly losses since March, markets were enjoying a broadly positive start to this one as traders eyed progress in drug trials, with AstraZeneca saying tests on the candidate it is developing with Oxford University could be finished by the end of the year. And the head of Pfizer said the drug it is working on with BioNTech could be ready for distribution within months.